Colonoscopy Clinical Trial
— MSCTOfficial title:
Motorized Spiral Colonoscopy Trial (MSCT): A First Feasibility Trial
Verified date | July 2017 |
Source | Evangelisches Krankenhaus Düsseldorf |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of this study is to assess the feasibility and the safety of the Novel Motorized Spiral Endoscope to examine the colon. The study is conceived as proof of concept trial with the primary aim to achieve a cecal intubation rate of at least 90 % according to quality guidelines recommendations. All other clinically relevant quality parameters of standard colonoscopy will be evaluated as secondary aims comparable to our recent trial. This study represents the first clinical evaluation of using a motorized spiral assisted endoscope for examination of the colon with potential advantages for patients in terms of effectiveness and convenience of colonoscopy.
Status | Completed |
Enrollment | 30 |
Est. completion date | February 1, 2017 |
Est. primary completion date | February 1, 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Screening for colorectal neoplasia - Surveillance after previous polypectomy/endoscopic mucosal resection (EMR) - Positive results on colorectal cancer (CRC) screening tests - Evaluation of clinical symptoms of non overt gastrointestinal bleeding - Indeterminate iron-deficiency anaemia - Chronic diarrhoea - Indeterminate large-bowel symptoms requiring evaluation for colorectal disease Exclusion Criteria: - Age under 18 years - Health status American Society of Anesthesiologists classification (ASA) level = 3 - Pregnancy - Known coagulopathy (INR=2.0, Platelets < 70/nl) - Anti-platelet agents or anticoagulants (other than aspirin) within last 7 days - History of chronic inflammatory bowel disease - Previously identified colorectal polyps/lesions with indication for endoscopic resection - Any medical contraindication to standard colonoscopy - Any prior abdominal surgery of the mid or lower gastrointestinal tract (except uncomplicated appendectomy) - Known or suspected bowel obstruction or stenosis - Known hemorrhoids 3rd degree - Suspected perforation of the GI tract - Inability to tolerate sedation for any reason - Absence of a signed informed consent |
Country | Name | City | State |
---|---|---|---|
Germany | Evangelisches Krankenhaus | Dusseldorf |
Lead Sponsor | Collaborator |
---|---|
Evangelisches Krankenhaus Düsseldorf | Olympus |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Cecal intubation rate | 3 days | ||
Secondary | Ileum intubation rate | 3 days | ||
Secondary | Procedure time | 3 days | ||
Secondary | rate of need for external compression | external compression necessary during intervention, yes/no? | 3 days | |
Secondary | adenoma detection rate | 3 days | ||
Secondary | success rate for removal of polyps | 3 days | ||
Secondary | amount of propofol needed for sedation | 3 days | ||
Secondary | maximum level of sedation during procedure | sedation depth assessed by ESGE-guideline, level 1-3 | 3 days | |
Secondary | patient satisfaction score | 1-10 visual analog scale | 3 days | |
Secondary | adverse event rate | 3 days | ||
Secondary | maximum pain during procedure | 1-10 visual analog scale | 3 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04101097 -
Training and Validation of Models of Factors to Predict Inadequate Bowel Preparation Colonoscopy
|
||
Completed |
NCT03247595 -
Testing How Well Magnesium Citrate Capsules Work as Preparation for a Colonoscopy
|
N/A | |
Completed |
NCT04214301 -
An Open-Label Preference Evaluation of BLI800
|
Phase 4 | |
Withdrawn |
NCT05754255 -
Comparison of High-flow Oxygen With or Without Nasal Positive Airway Pressure (PAP) During Propofol Sedation for Colonoscopy in an Ambulatory Surgical Center
|
N/A | |
Recruiting |
NCT02484105 -
Comforting Conversation During Colonoscopy: A Trial on Patient Satisfaction
|
Phase 4 | |
Active, not recruiting |
NCT02264249 -
Residual Gastric Volume in Same Day Versus Split Dose and Evening Before Bowel Preparation
|
N/A | |
Terminated |
NCT01978509 -
The Affect of Low-Volume Bowel Preparation for Hospitalized Patients Colonoscopies
|
N/A | |
Completed |
NCT01964417 -
The Comparative Study Between Bowel Preparation Method
|
Phase 3 | |
Recruiting |
NCT01685970 -
Comparison of Same-day 2 Sachets Picosulfate Versus High Volume PEG for Afternoon Colonoscopy
|
Phase 3 | |
Completed |
NCT01518790 -
Short Course, Single-dose PEG 3350 for Colonoscopy Prep in Children
|
N/A | |
Recruiting |
NCT00748293 -
Achievement of Better Examinee Compliance on Colon Cleansing Using Commercialized Low-Residue Diet
|
N/A | |
Completed |
NCT00779649 -
MoviPrep® Versus HalfLytely®, Low-VolUme PEG Solutions for Colon Cleansing: An InvesTigator-blindEd, Randomized, Trial
|
Phase 4 | |
Completed |
NCT00671177 -
Clinical Evaluation of Water Immersion Colonoscopy Insertion Technique
|
N/A | |
Completed |
NCT00380497 -
Pico-Salax Versus Poly-Ethylene Glycol for Bowel Cleanout Before Colonoscopy in Children
|
Phase 4 | |
Recruiting |
NCT00160823 -
Impact of a Self-Administered Information Leaflet on Adequacy of Colonic Cleansing for in-Hospital Patients
|
Phase 3 | |
Completed |
NCT00314418 -
Patient Position and Impact on Colonoscopy Time
|
N/A | |
Completed |
NCT00390598 -
PEG Solution (Laxabon®) 4L Versus Senna Glycoside (Pursennid® Ex-Lax) 36mg and PEG Solution (Laxabon®) 2L for Large Bowel Cleansing Prior to Colonoscopy
|
Phase 2/Phase 3 | |
Completed |
NCT00427089 -
Comparison of 2L NRL994 With NaP Preparation in Colon Cleansing Prior to Colonoscopies for Colon Tumor Screening
|
Phase 3 | |
Completed |
NCT00209573 -
A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients Undergoing Elective Colonoscopy
|
Phase 3 | |
Completed |
NCT05823350 -
The Effect of Abdominal Massage on Pain and Distention After Colonoscopy
|
N/A |